Arcadia Biosciences (RKDA) Return on Equity (2015 - 2025)

Arcadia Biosciences has reported Return on Equity for 11 years, with the latest figure at 0.0% in Q3 2025.

• For the quarter ending Q3 2025, Return on Equity rose 1.0% year-over-year to 0.0%; the trailing twelve-month figure through Sep 2025 stood at 0.0% (up 1.0% YoY), and the FY2024 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Equity for Q3 2025 stood at 0.0%, up from 0.0% in the prior quarter.
• The five-year high for Return on Equity was 0.0% in Q3 2021, with the low at 0.01% in Q1 2024.
• Historically, Return on Equity has averaged 0.0% across 5 years, with a median of 0.0% in 2021.
• Annual changes were most pronounced in 2021 — Return on Equity gained 1 bps — and 2024, when it slipped 1 bps.
• Arcadia Biosciences' Return on Equity stood at 0.0% in 2021, then tumbled by 97 bps to 0.0% in 2022, then slumped by 53 bps to 0.01% in 2023, then soared by 51 bps to 0.0% in 2024, then surged by 98 bps to 0.0% in 2025.
• The last three Return on Equity figures came in at 0.0% (Q3 2025), 0.0% (Q2 2025), and 0.0% (Q1 2025), per Business Quant data.